These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16365284)

  • 1. The growth of business firms: theoretical framework and empirical evidence.
    Fu D; Pammolli F; Buldyrev SV; Riccaboni M; Matia K; Yamasaki K; Stanley HE
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18801-6. PubMed ID: 16365284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamics of firms' growth.
    Zambrano E; Hernando A; Fernández Bariviera A; Hernando R; Plastino A
    J R Soc Interface; 2015 Nov; 12(112):. PubMed ID: 26510828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The size variance relationship of business firm growth rates.
    Riccaboni M; Pammolli F; Buldyrev SV; Ponta L; Stanley HE
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19595-600. PubMed ID: 19066227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percolation model for growth rates of aggregates and its application for business firm growth.
    Fu D; Buldyrev SV; Salinger MA; Stanley HE
    Phys Rev E Stat Nonlin Soft Matter Phys; 2006 Sep; 74(3 Pt 2):036118. PubMed ID: 17025719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size-dependent standard deviation for growth rates: empirical results and theoretical modeling.
    Podobnik B; Horvatic D; Pammolli F; Wang F; Stanley HE; Grosse I
    Phys Rev E Stat Nonlin Soft Matter Phys; 2008 May; 77(5 Pt 2):056102. PubMed ID: 18643131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean field approximation for biased diffusion on Japanese inter-firm trading network.
    Watanabe H
    PLoS One; 2014; 9(3):e91704. PubMed ID: 24626149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholders, innovative business models for the circular economy and sustainable performance of firms in an emerging economy facing institutional voids.
    Chiappetta Jabbour CJ; Seuring S; Lopes de Sousa Jabbour AB; Jugend D; De Camargo Fiorini P; Latan H; Izeppi WC
    J Environ Manage; 2020 Jun; 264():110416. PubMed ID: 32217311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finite-size effects in transcript sequencing count distribution: its power-law correction necessarily precedes downstream normalization and comparative analysis.
    Wong WC; Ng HK; Tantoso E; Soong R; Eisenhaber F
    Biol Direct; 2018 Feb; 13(1):2. PubMed ID: 29433547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests of scaling and universality of the distributions of trade size and share volume: evidence from three distinct markets.
    Plerou V; Stanley HE
    Phys Rev E Stat Nonlin Soft Matter Phys; 2007 Oct; 76(4 Pt 2):046109. PubMed ID: 17995062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical R&D performance by firm size: approval success rates and economic returns.
    DiMasi JA
    Am J Ther; 2014; 21(1):26-34. PubMed ID: 23344103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taylor's power law of fluctuation scaling and the growth-rate theorem.
    Cohen JE
    Theor Popul Biol; 2013 Sep; 88():94-100. PubMed ID: 23689021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Business angels and firm performance: First evidence from population data.
    Lodefalk M; Andersson FW
    PLoS One; 2023; 18(3):e0283690. PubMed ID: 36996067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition-induced criticality in a model of meme popularity.
    Gleeson JP; Ward JA; O'Sullivan KP; Lee WT
    Phys Rev Lett; 2014 Jan; 112(4):048701. PubMed ID: 24580496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of cryptocurrency coins and tokens by the dynamics of their market capitalizations.
    Wu K; Wheatley S; Sornette D
    R Soc Open Sci; 2018 Sep; 5(9):180381. PubMed ID: 30839686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust Characterization of Multidimensional Scaling Relations between Size Measures for Business Firms.
    Kobayashi Y; Takayasu H; Havlin S; Takayasu M
    Entropy (Basel); 2021 Jan; 23(2):. PubMed ID: 33573072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do agribusinesses thrive through complexity? The pivotal role of e-commerce capability and business agility.
    Lin J; Li L; Luo XR; Benitez J
    Decis Support Syst; 2020 Aug; 135():113342. PubMed ID: 32834263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-licensing as a business model.
    Schafer DP
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE36-9. PubMed ID: 12089585
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines as a global imperative--a business perspective.
    Stéphenne J
    Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Pivoting" by food industry firms to cope with COVID-19 in developing regions: E-commerce and "copivoting" delivery intermediaries.
    Reardon T; Heiman A; Lu L; Nuthalapati CSR; Vos R; Zilberman D
    Agric Econ; 2021 May; 52(3):459-475. PubMed ID: 34230730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An empirical analysis of the multimarket contact theory in pharmaceutical markets.
    Coronado J; Jiménez-Martín S; Marín PL
    Eur J Health Econ; 2014 Jul; 15(6):623-43. PubMed ID: 23818281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.